Novo Nordisk's next-generation weight-loss drug CagriSema matches Lilly Zepbon's big trial, but no more.-Waukeshahealthinsurance.com
Waukeshahealthinsurance.com- – In 2017, the Olympics burst onto the scene Approval For type 2 diabetes, drugmakers Novo Nordisk and Eli L…